Correlation Between Orient Pharma and Tsh Biopharmoration

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Orient Pharma and Tsh Biopharmoration at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orient Pharma and Tsh Biopharmoration into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orient Pharma Co and tsh biopharmoration, you can compare the effects of market volatilities on Orient Pharma and Tsh Biopharmoration and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orient Pharma with a short position of Tsh Biopharmoration. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orient Pharma and Tsh Biopharmoration.

Diversification Opportunities for Orient Pharma and Tsh Biopharmoration

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Orient and Tsh is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Orient Pharma Co and tsh biopharmoration in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on tsh biopharmoration and Orient Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orient Pharma Co are associated (or correlated) with Tsh Biopharmoration. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of tsh biopharmoration has no effect on the direction of Orient Pharma i.e., Orient Pharma and Tsh Biopharmoration go up and down completely randomly.

Pair Corralation between Orient Pharma and Tsh Biopharmoration

Assuming the 90 days trading horizon Orient Pharma Co is expected to generate 2.05 times more return on investment than Tsh Biopharmoration. However, Orient Pharma is 2.05 times more volatile than tsh biopharmoration. It trades about 0.0 of its potential returns per unit of risk. tsh biopharmoration is currently generating about -0.19 per unit of risk. If you would invest  3,725  in Orient Pharma Co on September 24, 2024 and sell it today you would lose (25.00) from holding Orient Pharma Co or give up 0.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Orient Pharma Co  vs.  tsh biopharmoration

 Performance 
       Timeline  
Orient Pharma 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Orient Pharma Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Orient Pharma showed solid returns over the last few months and may actually be approaching a breakup point.
tsh biopharmoration 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in tsh biopharmoration are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Tsh Biopharmoration is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Orient Pharma and Tsh Biopharmoration Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Orient Pharma and Tsh Biopharmoration

The main advantage of trading using opposite Orient Pharma and Tsh Biopharmoration positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orient Pharma position performs unexpectedly, Tsh Biopharmoration can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tsh Biopharmoration will offset losses from the drop in Tsh Biopharmoration's long position.
The idea behind Orient Pharma Co and tsh biopharmoration pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
CEOs Directory
Screen CEOs from public companies around the world